Medico-economic Evaluation of Immediately Sequential Bilateral Cataract Surgery Compared With Delayed Sequential Cataract Surgery in France

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

242 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-03

Study Completion Date

2029-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cataracts are defined as opacification of all or part of the crystalline lens, resulting in reduced vision. It is a common disease in France, affecting more than one in five people over the age of 65, and almost two in three over the age of 85. Cataract treatment is exclusively surgical. In the case of bilateral cataracts, which account for 70% of cases, Delayed Sequential Bilateral Cataract Surgery (DSBCS), which involves operating on both eyes with an interval of a few weeks, is the reference treatment in France. The practice of DSBCS has long been justified by the need to reduce the risk of post-operative complications, essentially refractive error and bilateral endophthalmitis. Today, thanks to numerous technological advances in cataract surgery and new intraoperative standards, these complications have become exceptional. Since 2009, the International Society of Bilateral Cataract Surgeons (ISBCS) has issued a guide to best practice (the ''ISBCS General Principles for Excellence in ISBCS''), enabling surgery on both eyes to be performed on the same day in complete safety. As a result, Immediate Sequential Bilateral Cataract Surgery (ISBCS), which involves operating on both eyes on the same day, could be performed with no additional risk compared to SDBCS, while providing the same level of postoperative visual acuity. In view of these factors, we hypothesize that CCBIS would be an efficient alternative to DSBCS in cases of bilateral cataract, for the patient and his family, the hospital and the health insurance company. In addition, its adoption would reduce delays in access to treatment, thus promoting better access to care in the situation of growing demand for this treatment, particularly in areas with fewer medical facilities.

The aim of thisproject is to evaluate the associated costs and quality of life in comparison with CCBSD, based on a prospective, multicenter, randomized controlled trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cost-effectiveness of ISBCS vs. DSBCS

NCT03400124

Bilateral Cataract

COMPLETED NA

Endothelial Cell Loss After Phacoemulsification Intra and Supracapsular

NCT02535819

Cataracts

COMPLETED NA

Objective Measurements of the Opacification of the Lens After Vitrectomy

NCT04566237

Vitrectomy Cataract

COMPLETED NA

DMEK And Cataract Surgery: Comparison Of Sequential Versus Combined Procedure

NCT03355924

Cataract Corneal Graft

COMPLETED

Patient Reported Visual Satisfaction Following Same Day or Delayed Bilateral Cataract Surgery

NCT05069753

Bilateral Cataract Charles Bonnet Syndrome

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract Bilateral Bilateral Cataracts Bilateral Cataract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ISBCS

Both eyes will be operated on during the same surgical procedure. Surgery will be performed in accordance with the iSBCS (International Society of Bilateral Cataract Surgeons) General Principles for Excellence in ISBCS (Immediate Sequential Bilateral Cataract Surgery) \[12\] by investigating ophthalmic surgeons or co-investigators with at least two years' experience in cataract surgery.

Group Type EXPERIMENTAL

Immediatly sequential bilateral cataract surgery

Intervention Type PROCEDURE

Immediatly sequential bilateral cataract surgery

DSBCS

Only one eye will be operated on during the first surgiczal procedure. The second eye will be operated on during a second surgical procdure delayed from 3 weeks +/- 1 week. Surgeries will be performed according to current guidelines by investigating or co-investigating ophthalmic surgeons with at least two years' experience in cataract surgery.

Group Type ACTIVE_COMPARATOR

Delayed sequential bilateral cataract surgery

Intervention Type PROCEDURE

Delayed sequential bilateral cataract surgery : 3 weeks +/-1 week between the two procedures

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Immediatly sequential bilateral cataract surgery

Intervention Type PROCEDURE

Delayed sequential bilateral cataract surgery

Delayed sequential bilateral cataract surgery : 3 weeks +/-1 week between the two procedures

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age greater than or equal to 18 years
* Indication for non-combined cataract surgery under local anaesthesia in both eyes
* Patient scheduled for outpatient cataract surgery
* Availability of a caregiver/accompanying person on the day of surgery and for the 1st day post-surgery
* Resident in France
* Speak and understand French
* Consent to participate in the study
* Affiliated or beneficiary of social security

Exclusion Criteria

* Women of childbearing age
* Surgery scheduled under general anesthesia or combined with other eye surgeries
* Ocular tone \> 24 mm Hg in at least one eye on day of inclusion
* Presence of risk factors for refractive error :

Presence of keratoconus confirmed by corneal topography Extreme axial eye length (\< 21 mm or \> 27 mm) High myopia with posterior staphyloma History of corneal surgery (LASIK, surface laser, radial keratotomy)

\- Presence of risk factors for endophthalmitis : Ocular, periocular or adnexal infections Immunosuppression Uncontrolled diabetes

* Presence of risk factors for intraoperative complications Ocular, adnexal or anatomical abnormalities History of retinal detachment Lens dislocation or iridodonesis Black cataract or posterior polar cataract History of perforating or blunt ocular trauma
* Presence of risk factors for corneal edema (e.g. Fuchs' endothelial dystrophy)
* Presence of vision-related comorbidities (glaucoma, AMD, amblyopia, uveitis, etc.)
* Presence of diabetes with diabetic retinopathy or macular edema
* Patient unable to participate in follow-up (e.g., response to questionnaires)
* Presence of cognitive disorders that could affect the smooth running of surgery or response to questionnaires

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No